OhioHealth Blood and Marrow Transplant Program

OhioHealth Cancer Care has added a new Blood and Bone Marrow Transplant (BMT) program to our services. Launched in phases, the outpatient program opened on April 4 and transplants will begin in late summer/early fall 2022.

GMO is a process by which defective cells in the bone marrow or non-functioning cancerous cells are eliminated by chemotherapy and/or radiotherapy and then replaced by new healthy cells. The ultimate goal is to cure or at least control the disease.

The program is available system-wide to all eligible patients. It will be located at OhioHealth Riverside Methodist Hospital and OhioHealth Arthur GH Bing, MD, Cancer Center. Medical Director Yvonne Efebera, MD, MPHbrings over 20 years of international experience to OhioHealth Cancer Care.

“I am thrilled to have joined OhioHealth and to have this new BMT program impact the lives of patients in the community,” said Dr. Efebera. “Although new to OhioHealth, the program encompasses decades of medical experience, training and clinical trials. We will provide a comprehensive and compassionate environment to care for patients and help them cope not only with their cancer, but also with their mental, physical and emotional health.

The BMT program will serve patients with hematological or blood cancers, such as leukemia, lymphoma and multiple myeloma. Patients with non-cancer disorders, such as bone marrow failure, metabolic disorders and primary immunodeficiency disorders will also be served under this program.

“These diseases are very complex conditions to treat,” Dr. Efebera said. Patients’ acuity is severe and their treatment must be carefully managed. In fact, many medical specialties are drawn upon to support their care, including critical care, immunology, pulmonology, nephrology, cardiology, and, of course, hematology and oncology.

The program was developed after seeing a need for these services at OhioHealth.

“We realized that we were disrupting the continuity of care for our patients when we had to send patients who needed BMT services to other health systems,” said Praveen Dubey, MD, vice president of care for BMT. OhioHealth Cancer. “Having this program allows our patients to receive all of their care in one place, which is much more convenient for them. This new BMT program addresses the current unmet needs of our patients and allows us to maintain the continuity of safe, high-quality care for patients closer to home and within our system.

The number of BMTs continues to rise steadily in the United States and is expected to increase by 9% over the next five years. OhioHealth hopes to do 150 transplants a year over the next five years.

An inpatient unit is currently being built within the 17,000 square feet of existing space at Riverside Methodist Hospital and a 10,000 square foot portion of the atrium level of the Bing Cancer Center, previously occupied by conference room spaces, has been converted to include infusion space for BMT patients, ambulatory care and outpatient clinics, a laboratory and a pharmacy.

‘, ‘window.fbAsyncInit = function() {‘, ‘FB.init({‘, ‘appId:’216372371876365′,’, ‘xfbml:true,’, ‘version: ‘v2.6” , ‘});’ ]; ppLoadLater.placeholderFBSDK.push(‘_ga.trackFacebook();’); ppLoadLater.placeholderFBSDK.push(‘};’); var ppFacebookSDK = [
‘(function(d, s, id) {‘,
‘var js, fjs = d.getElementsByTagName(s)[0];’, ‘if (d.getElementById(id)) return;’, ‘js = d.createElement(s); js.id = id;’, ‘js.src = “https://connect.facebook.net/en_US/sdk.js”;’, ‘fjs.parentNode.insertBefore(js, fjs);’, ‘}( document, ‘script’, ‘facebook-jssdk’));’ ]; ppLoadLater.placeholderFBSDK = ppLoadLater.placeholderFBSDK.concat(ppFacebookSDK); ppLoadLater.placeholderFBSDK.push(‘‘); ppLoadLater.placeholderFBSDK = ppLoadLater.placeholderFBSDK.join(“n”);

Ryan H. Bowman